Payer+Provider's Health System Review
FDA delays decision on whether Juul e-cigarettes will be banned
It’s Not Just Covid: Recall Candidates Represent Markedly Different Choices on Health Care
September 10, 2021
Juul and Vuse, the second-most popular brand, accounted for nearly four out of five dollars spent on e-cigarettes in 2020.
Read the full post on Forbes - Healthcare